Li Jin

Dr. Li Jin, President of Fudan University and Dean of Shanghai Medical College, Director of Human Phenome Institute. He is a member of Chinese Academy of Science and an external member of Max-Planck Society. Prior to this latest responsibility, Prof JIN had served as Dean of School of Life Sciences, Dean of Graduate School, Vice President and Executive Vice President of Fudan University. 

He received his PhD from University of Texas (UT) – Health Science Center at Houston. He was a faculty member at UT School of Public Health and Professor at University of Cincinnati College of Medicine before he joined Fudan University in 2003.

Dr. JIN’s main research areas encompass genetic structure and migrations of human populations, genetics of human complex diseases and computational biology. To date, he has published more than 900 papers in international academic journals including Nature, Science, Cell, NEJM, JAMA etc. and his papers have been cited 50,000 times. He has won numerous awards including State Award of Natural Sciences twice, C.C. Tan Life Science Achievement Award, Distinguished Academic Achievement Award of Human Genome Organization (HUGO), Prize for Scientific and Technological Progress of Ho-Leung-Ho-Lee Foundation. 

He served as a board member of HUGO, co-founded Genographic Project, Pan-Asian SNP Consortium, and International Human Phenome Consortium (IHPC). He also co-founded National Human Genome Center at Shanghai, CAS-MPG Partner Institute of Computational Biology, Shanghai International Human Phenome Institute. At Fudan University, he founded Department of Human Genetics and Anthropology, Academy of Engineering and Technology, Taizhou Institute of Health Sciences, and Institute of Modern Linguistics. He also serves as Vice President of the Genetics Society of China, Vice Chairperson of the Chinese Society of Anthropology, and Chairperson of the Top University League of World Laureate Association 

Dr. Jin has served as editor-in-chief and editorial board member of more than 10 international journals, including Phenomics. He has chaired three national councils including Frontier Biotechnology in the National High-tech R&D Program, National Precision Medicine Research Program, and National Biotechnology and Information Technology Convergence Program.